Alprazolam

Basic Information

Item Value
DrugBank ID DB00404
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 30

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 insomnia (disease) KG + DL
2 benign paroxysmal torticollis of infancy KG + DL
3 agoraphobia KG + DL
4 attention deficit-hyperactivity disorder KG + DL
5 attention deficit hyperactivity disorder, inattentive type KG + DL
6 obsessive-compulsive disorder KG + DL
7 chondromyxoid fibroma KG + DL
8 specific developmental disorder KG + DL
9 faciodigitogenital syndrome KG + DL
10 phobic disorder KG + DL
11 schizotypal personality disorder KG + DL
12 paranoid personality disorder KG + DL
13 histrionic personality disorder (disease) KG + DL
14 schizoid personality disorder KG + DL
15 sleep disorder, initiating and maintaining sleep KG + DL
16 endogenous depression KG + DL
17 major depressive disorder KG + DL
18 manic bipolar affective disorder KG + DL
19 major affective disorder KG + DL
20 acute encephalopathy with biphasic seizures and late reduced diffusion KG + DL
21 dependent personality disorder KG + DL
22 neurotic depression KG + DL
23 melancholia KG + DL
24 unipolar depression KG + DL
25 narcissistic personality disorder KG + DL
26 REM sleep behavior disorder KG + DL
27 Ohdo syndrome and variants KG + DL
28 avoidant personality disorder KG + DL
29 myofascial pain syndrome KG + DL
30 Keppen-Lubinsky syndrome KG + DL

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.